Why the study?
In patients with AF and advanced renal failure, the use of DOACs is controversial due to limited clinical data testing their efficacy and safety compared to VKAs.
Are direct oral anticoagulants safe and effective alternatives to vitamin K antagonists in patients with atrial fibrillation and advanced renal failure?
Population
Patients with AF and advanced renal insufficiency
Comparison
DOACs vs VKAs
Authors
Loading...
Should not yet change practice in advanced renal failure; warrants RCTs to confirm renal preservation with DOACs.
Are direct oral anticoagulants safe and effective alternatives to vitamin K antagonists in patients with atrial fibrillation and advanced renal failure?
In patients with AF and advanced renal failure, DOACs may offer an advantage over VKAs by reducing the deterioration of renal function and avoiding VKA-associated nephropathy and calcification.
Rossini et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: